Synthekine

Synthekine

  • Founded: 2018
  • Location: Menlo Park, CA
  • Employee range: 50 - 200
  • Clinical stage: Clin1
  • Therapy area: Immuno-oncology
  • Drug types: ONC, IMM
  • Lead product: STK-012
  • Product link: https://www.synthekine.com/our-pipeline/
  • Funding: $100M C Jan 2023; $107.5M B Jun 2021; $82M A Sep 2020
  • Investors: The Column Group


synthekine.com

linkedin.com

job board


Short description:

Engineered Cytokines

Drug notes:

STK-009 2 efforts Clin0/Clin1oncology; undisclosed Clin0 immuno-oncology; 2 undisclosed programs RD/Clin0 autoimmune conditions

Long description:

Contact us to add description: recruit@workinbiotech.com

Jobs:

Synthekine
Scientist II / Sr. Scientist, Translational Pathol...
Menlo Park, CA|53 days ago
Apply
Synthekine
Scientist I, Translational and Bioanalytical Scien...
Menlo Park, CA|64 days ago


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com